BrightSpring Health Services, Inc.
For the period ended Sep 30, 2026. Filed Oct 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 30, 2026
BTSG$72.49+4.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
| For the Nine Months Ended | ||
|---|---|---|
| September 30, | ||
| 2026 | 2025 | |
| Operating activities: | ||
| Net income | $333,118 | $111,793 |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||
| Depreciation and amortization | 118,889 | 124,753 |
| Impairment of long-lived assets | 8,240 | 6,526 |
| Change in fair value of contingent consideration, net | — | (1,266) |
| Payment of contingent consideration in excess of acquisition date fair value | — | (6,170) |
| Provision for credit losses | 28,694 | 48,723 |
| Amortization of deferred debt issuance costs | 8,317 | 8,384 |
| Share-based compensation | 41,040 | 55,733 |
| Deferred income taxes, net | (3,045) | 18,266 |
| Gain on sale of discontinued operations | (101,845) | — |
| Other | 243 | (335) |
| Change in operating assets and liabilities, net of acquisitions and dispositions: | ||
| Accounts receivable | (235,949) | (162,689) |
| Prepaid expenses and other current assets | (41,057) | 24,857 |
| Inventories | 143,408 | (2,279) |
| Trade accounts payable | 54,920 | 42,836 |
| Accrued expenses | 47,186 | 17,212 |
| Other assets and liabilities | (30,978) | (27,734) |
| Net cash provided by operating activities | $371,181 | $258,610 |
| Investing activities: | ||
| Purchases of property and equipment | $(72,666) | $(57,819) |
| Acquisitions of businesses | (44,132) | (8,308) |
| Proceeds from sale of discontinued operations | 810,908 | — |
| Other | 1,893 | (5,068) |
| Net cash provided by (used in) investing activities | $696,003 | $(71,195) |
| Financing activities: | ||
| Long-term debt repayments | $(332,300) | $(37,933) |
| Repayments of the Revolving Credit Facility, net | — | (63,300) |
| Payments of debt issuance costs | (3,378) | — |
| Repurchases of shares of common stock | (120,000) | — |
| Proceeds from shares issued under share-based compensation plan | 37,256 | 14,681 |
| Taxes paid related to net share settlement of equity awards | (11,548) | (5,583) |
| Purchase of redeemable noncontrolling interest | (267) | (5,100) |
| Payments of financing lease obligations | (7,584) | (10,133) |
| Net cash used in financing activities | $(437,821) | $(107,368) |
| Net increase in cash and cash equivalents | 629,363 | 80,047 |
| Cash and cash equivalents at beginning of period | 88,477 | 61,253 |
| Cash and cash equivalents at end of period | $717,840 | $141,300 |
| Cash and cash equivalents included in assets held for sale at end of period | — | 956 |
| Cash and cash equivalents included in continuing operations at end of period | $717,840 | $140,344 |
Condensed Consolidated Statements of Cash Flows (continued)
| For the Nine Months Ended | ||
|---|---|---|
| September 30, | ||
| 2026 | 2025 | |
| Supplemental disclosures of cash flow information: | ||
| Cash paid for: | ||
| Interest, net | $102,994 | $137,872 |
| Income taxes, net of refunds | $158,888 | $14,851 |
| Supplemental schedule of non-cash investing and financing activities: | ||
| Note issued in connection with an acquisition | $200 | $— |
| Financing lease obligations assumed | $4,851 | $10,452 |
| Purchases of property and equipment in accounts payable | $2,615 | $2,856 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.